Research
Hormonal
The BP reduction effect of GLP-1 RAs was consistent across subgroups for diabetic status, formulation, follow-up duration, and route of administration.
GLP-1 receptor agonists can be effectively used across different patient subgroups for BP management.
StrongSupportsmedium confidence
This effect was consistent across subgroups for diabetic status, formulation of GLP-1 RA, follow-up duration and route of administration for both SBP and DBP.
Why this rating
Supported by the analysis of multiple RCTs.
Source
Effects of glucagon-like peptide-1 receptor agonists on blood pressure in overweight or obese patients: a meta-analysis of randomized controlled trials
Hon Jen Wong et al. · Journal of Hypertension · 2024
Meta-analysisCited 17×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →